Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Myovant Sciences Ltd.

    NYSE: MYOV · Real-Time Price · USD
    26.98
    -0.01 (-0.04%)
    At close: Mar 09, 2023, 10:01 PM

    Myovant Sciences Statistics

    Share Statistics

    Myovant Sciences has 97.26M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 97.26M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 50.86M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,096,604

    FTD / Avg. Volume

    n/a
    		 100.51%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -6.01 and the forward PE ratio is null. Myovant Sciences's PEG ratio is 0.28.

    PE Ratio

    n/a
    		 -6.01

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 5.36

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -2.62

    P/FCF Ratio

    n/a
    		 -4.59

    PEG Ratio

    n/a
    		 0.28
    Financial Ratio History

    Enterprise Valuation

    Myovant Sciences has an Enterprise Value (EV) of 1.2B.

    EV / Sales

    n/a
    		 5.19

    EV / EBITDA

    n/a
    		 -6.52

    EV / EBIT

    n/a
    		 -4.47

    EV / FCF

    n/a
    		 -4.45

    Financial Position

    The company has a current ratio of 1.95, with a Debt / Equity ratio of -0.78.

    Current Ratio

    n/a
    		 1.95

    Quick Ratio

    n/a
    		 1.92

    Debt / Equity

    n/a
    		 -0.78

    Debt / EBITDA

    n/a
    		 -2

    Debt / FCF

    n/a
    		 -1.36

    Interest Coverage

    n/a
    		 -13.41

    Financial Efficiency

    Return on Equity is 43.5% and Return on Invested Capital is 181.89%.

    Return on Equity

    n/a
    		 43.5%

    Return on Assets

    n/a
    		 -39.61%

    Return on Invested Capital

    n/a
    		 181.89%

    Revenue Per Employee

    n/a
    		 $398,915.37

    Profits Per Employee

    n/a
    		 $-355,753.02

    Employee Count

    n/a
    		 579

    Asset Turnover

    n/a
    		 0.44

    Inventory Turnover

    n/a
    		 6.8

    Taxes

    Income Tax

    n/a
    		 5.05M

    Effective Tax Rate

    n/a
    		 -2.51%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 2.15, so Myovant Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.15

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 26.92

    200-Day Moving Average

    n/a
    		 21.14

    Relative Strength Index (RSI)

    n/a
    		 61.01

    Average Volume (20 Days)

    n/a
    		 1,091,060

    Income Statement

    In the last 12 months, Myovant Sciences had revenue of 230.97M and earned -205.98M in profits. Earnings per share was -2.22.

    Revenue

    n/a
    		 230.97M

    Gross Profit

    n/a
    		 179.42M

    Operating Income

    n/a
    		 -187.35M

    Net Income

    n/a
    		 -205.98M

    EBITDA

    n/a
    		 -183.89M

    EBIT

    n/a
    		 -186.96M

    Earnings Per Share (EPS)

    n/a
    		 -2.22
    Full Income Statement

    Balance Sheet

    The company has 406.7M in cash and 367.89M in debt, giving a net cash position of 38.81M.

    Cash & Cash Equivalents

    n/a
    		 406.7M

    Total Debt

    n/a
    		 367.89M

    Net Cash

    n/a
    		 38.81M

    Retained Earnings

    n/a
    		 -1.25B

    Total Assets

    n/a
    		 403.52M

    Working Capital

    n/a
    		 140.83M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -268.56M and capital expenditures -974K, giving a free cash flow of -269.53M.

    Operating Cash Flow

    n/a
    		 -268.56M

    Capital Expenditures

    n/a
    		 -974K

    Free Cash Flow

    n/a
    		 -269.53M

    FCF Per Share

    n/a
    		 -2.9
    Full Cash Flow Statement

    Margins

    Gross margin is 77.68%, with operating and profit margins of -81.11% and -89.18%.

    Gross Margin

    n/a
    		 77.68%

    Operating Margin

    n/a
    		 -81.11%

    Pretax Margin

    n/a
    		 -86.99%

    Profit Margin

    n/a
    		 -89.18%

    EBITDA Margin

    n/a
    		 -79.62%

    EBIT Margin

    n/a
    		 -81.11%

    FCF Margin

    n/a
    		 -116.7%

    Dividends & Yields

    MYOV does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -16.63%

    FCF Yield

    n/a
    		 -21.76%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for MYOV.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 15.93

    Graham Upside

    n/a
    		 -40.96%

    Scores

    Altman Z-Score

    n/a
    		 -2.98

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist